IPP Bureau
AstraZeneca launches up-skilling program iPHARMACY
By IPP Bureau - September 15, 2022
The company has partnered with Neethi, a Kerala state cooperative consumers federation limited company, to run this program in Kerala
Dr. Jaidev Rajpal appointed MD & CEO of Jubilant Generics
By IPP Bureau - September 15, 2022
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
Zydus receives final approval from USFDA for Cariprazine Capsules
By IPP Bureau - September 15, 2022
Cariprazine is an atypical antipsychotic indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder
Alkem Laboratories appoints Srinivas Singh as Executive Director
By IPP Bureau - September 15, 2022
He holds a Bachelor’s Degree in Science and has joined the company in 2012 and has over 10 years of experience in pharmaceutical industry
Lupin receives Health Canada approval for Rymti
By IPP Bureau - September 14, 2022
Rymti is indicated in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, axial spondyloarthritis, plaque psoriasis, and paediatric plaque psoriasis
Mandaviya launches NLEM 2022
By IPP Bureau - September 14, 2022
This will give a boost to cost-effective, quality medicines and contribute towards reduction in out of pocket expenditure on healthcare for the citizens
ProBioGen receives Employer of the Future and the Top Service awards
By IPP Bureau - September 14, 2022
They also noted ProBioGen's digitalization investments and strategy, as well as its support for its employees.
Philips Foundation and RAD-AID International embark on a multi-year cross-continental partnership
By IPP Bureau - September 14, 2022
Philips Foundation and RAD-AID International leverage Philips’ expertise in mobile ultrasound services to improve access to virtual care in hard-to-reach areas
Takara Bio partners with BioeXsen for the distribution of CE-IVD solutions
By IPP Bureau - September 14, 2022
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
Medvarsity partners Wolters Kluwer to improve learning outcomes
By IPP Bureau - September 13, 2022
This association between the two esteemed organizations allows Medvarsity to significantly – and positively – impact healthcare education
Tata Memorial Centre suggests low-cost intervention for breast cancer
By IPP Bureau - September 13, 2022
If implemented across the world, it has the capability to save over 100,000 lives annually
Lonza appoints Daniel Palmacci as President of the Cell & Gene Division
By IPP Bureau - September 13, 2022
He takes over leadership of Cell & Gene from Jean-Christophe Hyvert, enabling Jean-Christophe to increase his focus on his role as President of the Biologics Division
AIIA launches 6-week long Ayurveda Day 2022 Programme
By IPP Bureau - September 13, 2022
The programme will see participation from various ministries of the Government of India with the aim of 3Js – Jan Sandesh, Jan Bhagidari, and Jan Aandolan.
AstraZeneca likely to see substantial Evusheld uptake in Japan, says GlobalData
By IPP Bureau - September 13, 2022
Japan’s Ministry of Health, Labour and Welfare (MHLW) has recently approved AstraZeneca's long-acting antibody combination “Evusheld” for the prevention ) and treatment of COVID-19.
Auretics Introduces its range of ayurvedic products
By IPP Bureau - September 13, 2022
This includes Madhurodhi, HBP Care & LBP Care for sugar & BP patients
